Medicus Pharma Ltd. -29MDCXWPreferred / convertible
13F holders, Q4 2025 (December 31)5holders
0new positions
1sold out
$0.98avg. 13F price*
At the end of Q4 2025, 5 institutions reported holding Medicus Pharma Ltd. -29 (MDCXW) in their 13F filings, unchanged from Q3 2025. 0 opened new positions and 1 sold out. The largest holders were Anson Funds Management LP ($65K), Armistice Capital, LLC ($48K) and Private Advisor Group, LLC ($39K).
- Company
- Medicus Pharma Ltd. -29
- CUSIP
- 58471K111
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $12K |
All 13F filers, Q3 2025 → Q4 2025: 5,000 shares bought and 17,203 shares sold, net −12,203 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Anson Funds Management LP | — | No change | 42,400 | $65K |
| Armistice Capital, LLC | — | No change | 60,600 | $48K |
| Private Advisor Group, LLC | — | Add +11.4% | 49,000 | $39K |
| Empery Asset Management, LP | — | — | 12,100 | $10K |
| Connective Capital Management, LLC | — | No change | 6,000 | $5K |
"% of holder's portfolio" is MDCXW's weight in each manager's 13F, not the share of Medicus Pharma Ltd. -29 the manager owns.